Skip to content

Clinical trials

Terminated Adenocarcinoma trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenocarcinoma Status: Terminated Country / region: United States Clear all

51 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20053
20063
20081
20091
20103
20113
20122
20132
20142
20155
20175
20182
20193
20204
20213
20223
20233
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated51

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Blueprint Medicines Corporation3
Elevation Oncology2
H. Lee Moffitt Cancer Center and Research Institute2
M.D. Anderson Cancer Center2
Mayo Clinic2
National Cancer Institute (NCI)2
Stanford University2
Washington University School of Medicine2
AbGenomics B.V Taiwan Branch1
Abbott1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenocarcinoma51
Neoplasms14
Carcinoma, Non-Small-Cell Lung11
Pancreatic Neoplasms10
Carcinoma9
Neoplasm Metastasis7
Stomach Neoplasms7
Carcinoma, Squamous Cell6
Lung Neoplasms6
Neoplasms by Site6

Trials

Showing 1 to 25 of 51. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.